BioSpace News Archive

July 28, 2020 12:00 UTC --Next-wave engineered protein company with pipeline of cytokine therapeutics developed in Versant’s Ridgeline Discovery Engine-- --First IL-2 development candidate shows superior properties to all known competitors-- --Industry veteran Sef Kurstjens joins as president and CEO--

Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor (“CGM”), together with BEAT®diabetes, a planned health subscription service designed to help people with Type 2 diabetes and pre-diabetes through personaliz

Nascent Biotech, Inc. (OTCQB:NBIO), announced today it has entered into a research collaboration with Syracuse University to further the development of Pritumumab, a unique monoclonal antibody that binds to cell-surface vimentin, for potential use in COVID-19 treatment.

SignPost Cancer Dx Inc., a company developing an advanced molecular diagnostic test to identify invasive breast cancer, is pleased to announce the filing of a provisional patent for the companys lead diagnostic test - BreastDefense. SignPost

Resumption of its PLENITUDE© clinical trial on-time; CAUMZ™ manufacturing set to begin in USA to allow start of clinical trials; QIXLEEF™ metabolite mapping study to be complete in Q3 2020

Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating organ damage caused by inflammation, today announced that it has chosen its first U.S. clinical site for the Phase II trial of its lead drug LSALT peptide (Metablok).

Zymo Research recently has released a free open-source software program that allows California laboratories to rapidly report COVID-19 test data to the California Reportable Disease Information Exchange.

American Screening, LLC, a premier domestic and international manufacturer and distributor of diagnostic products and essential medical supplies, is pleased to announce the addition of a COVID-19 IgG/IgM rapid test to its inventory.

Neocortix, a mobile distributed computing company, today announced the release of Arm® 64-bit support for two leading protein folding research projects – Folding@home and Rosetta@home.

Logos Technologies recently received approval to disclose that it has been awarded a $6.7 million contract from the U.S. Naval Air Systems Command (NAVAIR) to develop, deliver, and perform proof-of-concept flight tests on a wide-area motion imagery (WAMI) sensor. The sensor system will be called Cardcounter and is being developed to i